XOMA Corp at Cowen Health Care Conference Transcript
Welcome to the 39th annual Cowen and Company healthcare conference. I am Joe Thome, one of the members of the biotech team here at Cowen.
It is my pleasure to introduce XOMA today and CEO Jim Neal, who is going to give us an update on the Company.
Thank you, Joe. Welcome. With me today I have Tom Burns, our CFO, here to answer questions should we get to that point. And also with Tom is Juliane Snowden, who handles our investor relations.
So welcome to the XOMA story. It is a biotech story that doesn't look like a biotech story. I hope you appreciate I think a very interesting model that we actually introduced exactly two years ago at this conference and have been working diligently to make effective since that point in time.
We will be making forward-looking statements. I would refer you to our SEC filings to apprise yourself of the risks associated with investing in biotech, which we all are very aware of.
Let's just talk about XOMA and what we are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |